NBE Trademark

Trademark Overview


On Thursday, January 16, 2003, a trademark application was filed for NBE with the United States Patent and Trademark Office. The USPTO has given the NBE trademark a serial number of 78204170. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, April 30, 2004. This trademark is owned by Direvo BioTech AG. The NBE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases, especially infectious diseases, hereditary diseases, metabolic diseases, stroke and cardiac diseases, allergic diseases, angine, diabetes, insomnia, and as analgetics, anaestetics, anti-tumor agents, and for the treatment of adipoe; veterinary preparations, namely, for the treatment of diseases, especially infectious diseases, metabolic diseases, and allergic diseases, and as analgetics, anaestetics, and anti-tumor agents; veterinary vaccines for animals, especially bovine, sheep, horse, pork, poultry, and fish; sanitary preparations, namely, bactericides, algaecides, germicides, insecticides, enzymes, and fungicides; diagnostic preparations, namely, proteins and nucleic acids for clinical and medical laboratory use; clinical medical reagents, namely, proteins and nucleic acids; medical diagnostic reagents; kits comprised primarily of reagents, especially proteins, nucleic acids, enzymes and buffers, for molecular-biological me...

General Information


Serial Number78204170
Word MarkNBE
Filing DateThursday, January 16, 2003
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, April 30, 2004
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of diseases, especially infectious diseases, hereditary diseases, metabolic diseases, stroke and cardiac diseases, allergic diseases, angine, diabetes, insomnia, and as analgetics, anaestetics, anti-tumor agents, and for the treatment of adipoe; veterinary preparations, namely, for the treatment of diseases, especially infectious diseases, metabolic diseases, and allergic diseases, and as analgetics, anaestetics, and anti-tumor agents; veterinary vaccines for animals, especially bovine, sheep, horse, pork, poultry, and fish; sanitary preparations, namely, bactericides, algaecides, germicides, insecticides, enzymes, and fungicides; diagnostic preparations, namely, proteins and nucleic acids for clinical and medical laboratory use; clinical medical reagents, namely, proteins and nucleic acids; medical diagnostic reagents; kits comprised primarily of reagents, especially proteins, nucleic acids, enzymes and buffers, for molecular-biological medical laboratory use and medical diagnostics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 10, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDirevo BioTech AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKoln D-50829
DE

Trademark Events


Event DateEvent Description
Friday, April 30, 2004ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 10, 2003NON-FINAL ACTION MAILED
Sunday, June 29, 2003ASSIGNED TO EXAMINER